CN107260705A - A kind of preparation method of Aprepitant Nano capsule - Google Patents

A kind of preparation method of Aprepitant Nano capsule Download PDF

Info

Publication number
CN107260705A
CN107260705A CN201710429116.0A CN201710429116A CN107260705A CN 107260705 A CN107260705 A CN 107260705A CN 201710429116 A CN201710429116 A CN 201710429116A CN 107260705 A CN107260705 A CN 107260705A
Authority
CN
China
Prior art keywords
aprepitant
gelatin
parts
acetic acid
capsule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710429116.0A
Other languages
Chinese (zh)
Inventor
彭凡
李娜
田军
叶杨欢
陈金利
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wuhan Lihe Biological Pharmaceutical Co Ltd
Original Assignee
Wuhan Lihe Biological Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wuhan Lihe Biological Pharmaceutical Co Ltd filed Critical Wuhan Lihe Biological Pharmaceutical Co Ltd
Priority to CN201710429116.0A priority Critical patent/CN107260705A/en
Publication of CN107260705A publication Critical patent/CN107260705A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • A61K9/513Organic macromolecular compounds; Dendrimers
    • A61K9/5169Proteins, e.g. albumin, gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol

Abstract

The present invention relates to pharmaceutical technology field, especially a kind of preparation method of Aprepitant Nano capsule, including getting the raw materials ready, the dissolving of gelatin, the dissolving of powder Aprepitant, the configuration of acetic acid solution, the mixing of raw material and detecting step, auspicious prepared smooth Nano capsule improves auspicious smooth water solubility and bioavilability, reduce toxic side effect, improve medicine stability, during disease is treated, both it is orally available and can injection injection, because there is gelatin coatings when oral, just start to play drug effect after stomach is entered, alleviate to gastral toxic side effect, its Nano capsule diameter reaches Nano grade when injection is injected, thrombus is not resulted in the blood vessel, the place of illness can be smoothly reached with blood circulation, directly focus is acted on, it can be good at playing drug effect, having reached improves the therapeutic effect of Aprepitant medicine.

Description

A kind of preparation method of Aprepitant Nano capsule
Technical field
The present invention relates to pharmaceutical technology field, more particularly to a kind of preparation method of Aprepitant Nano capsule.
Background technology
Aprepitant is clinically mainly used in during the first and repetitive therapy of prevention height cause telling property anti-tumor chemotherapeutic The acute and Delayed onset nausea and vomiting occurred.Aprepitant is not dissolved in water, is metabolized soon, and bioavilability is low, therefore controls Dosage is larger when treating disease.Oral Aprepitant medicine is not allowed in water, absorbs slow, efficiency is low, have impact on treatment Effect.
The content of the invention
The invention aims to solve to have oral Aprepitant medicine in the prior art not allowing in water, absorb Slowly, efficiency is low, have impact on the shortcoming of therapeutic effect, and a kind of preparation method of the Aprepitant Nano capsule proposed.
To achieve these goals, present invention employs following technical scheme:
A kind of preparation method of Aprepitant Nano capsule is designed, is comprised the following steps:
S1, get the raw materials ready, take gelatin, distilled water, vacuumfilter, powder Aprepitant, acetic acid standby;
S2, gelatin dissolving, take 2-5 parts of gelatin in S1 to be dissolved in 70-100 parts of distilled water, in 20-24 DEG C stir at room temperature Mix to gelatin and be swelled to form colloid, suction filtration then is carried out to colloid using vacuumfilter, the impurity in colloid is removed;
S3, powder Aprepitant dissolving, take 2-5 parts of powder Aprepitant in S1 to be dissolved in 70-100 parts of ethanol, 20-24 DEG C of stirring at room temperature is completely dissolved powder Aprepitant;
S4, acetic acid solution configuration, glacial acetic acid are dissolved in distilled water, configure 7-10% acetic acid solution;
S5, raw material mixing, take 8-14 parts of gelatin in S2 after removal of impurities to be placed in beaker, are subsequently placed in 37-40 DEG C of perseverance Tepidarium is heated and stirred, and then takes 2-5 parts to be slowly added dropwise into gelatin solution the Aprepitant ethanol solution dissolved in S3, The acetic acid solution of 7-10% in S4 is added, regulation pH value is then cold how to room temperature between 4.8-5.1, and then makes Aprepitant Capsule solidifies, and obtains Nano capsule;
S6, detection, obtained nanocapsules mixture in S5 is irradiated using e-Pointer, Tyndall scattering inspection is carried out Survey.
It is preferred that, the gelatin, in cooling, puts the condition of mixture and ice bath with Aprepitant ethanol solution mixture Under, controller temperature is 1-4 degrees Celsius, and formaldehyde is slowly added dropwise stirs to Aprepitant capsule and be fully cured.
It is preferred that, the Aprepitant capsule after hardening, filtration sterilization processing is carried out using the filter membrane in 200nm apertures.
A kind of preparation method of Aprepitant Nano capsule proposed by the present invention, beneficial effect is:By preparing A Rui Smooth Nano capsule improves the water solubility and bioavilability of Aprepitant, reduces toxic side effect, improves medicine stability, During treating disease, it is both orally available and also can injection injection, because there is gelatin coatings when oral, just start hair after stomach is entered Drug effect is waved, is alleviated to gastral toxic side effect, its Nano capsule diameter reaches Nano grade when injection is injected, in the blood vessel Thrombus is not resulted in, the place of illness can be smoothly reached with blood circulation, directly focus is acted on, can be good at playing medicine Effect, having reached improves the therapeutic effect of Aprepitant medicine.
Embodiment
In order to make the purpose , technical scheme and advantage of the present invention be clearer, below in conjunction with specific embodiment, to this Invention is further elaborated.It should be appreciated that the specific embodiments described herein are merely illustrative of the present invention, not For limiting the present invention.
Embodiment one
A kind of preparation method of Aprepitant Nano capsule, comprises the following steps:
S1, get the raw materials ready, take gelatin, distilled water, vacuumfilter, powder Aprepitant, acetic acid standby;
S2, gelatin dissolving, take 2 parts of gelatin in S1 to be dissolved in 70 parts of distilled water, in 21 DEG C of stirrings at room temperature to gelatin It is swelled to form colloid, suction filtration then is carried out to colloid using vacuumfilter, the impurity in colloid is removed;
S3, powder Aprepitant dissolving, take 2 parts of powder Aprepitant in S1 to be dissolved in 70 parts of ethanol, at 21 DEG C Stirring is completely dissolved powder Aprepitant at room temperature;
S4, acetic acid solution configuration, glacial acetic acid are dissolved in distilled water, the acetic acid solution of configuration 7%;
S5, raw material mixing, take 8 parts of gelatin in S2 after removal of impurities to be placed in beaker, are subsequently placed in 37 DEG C of waters bath with thermostatic control Heat and stir, then take 2 parts to be slowly added dropwise into gelatin solution the Aprepitant ethanol solution dissolved in S3, add in S4 7% acetic acid solution, regulation pH value is then cold how to room temperature between 4.8, and then solidifies Aprepitant capsule, is received Rice glue capsule, gelatin and Aprepitant ethanol solution mixture in cooling, put mixture with conditions of ice bath, controller temperature For 1 degree Celsius, and formaldehyde is slowly added dropwise stirs to Aprepitant capsule and be fully cured, Aprepitant capsule after hardening, is used The filter membrane in 200nm apertures carries out filtration sterilization processing;
S6, detection, obtained nanocapsules mixture in S5 is irradiated using e-Pointer, Tyndall scattering inspection is carried out Survey.
Embodiment two
A kind of preparation method of Aprepitant Nano capsule, comprises the following steps:
S1, get the raw materials ready, take gelatin, distilled water, vacuumfilter, powder Aprepitant, acetic acid standby;
S2, gelatin dissolving, take 3 parts of gelatin in S1 to be dissolved in 80 parts of distilled water, in 22 DEG C of stirrings at room temperature to gelatin It is swelled to form colloid, suction filtration then is carried out to colloid using vacuumfilter, the impurity in colloid is removed;
S3, powder Aprepitant dissolving, take 3 parts of powder Aprepitant in S1 to be dissolved in 80 parts of ethanol, at 22 DEG C Stirring is completely dissolved powder Aprepitant at room temperature;
S4, acetic acid solution configuration, glacial acetic acid are dissolved in distilled water, the acetic acid solution of configuration 8%;
S5, raw material mixing, take 10 parts of gelatin in S2 after removal of impurities to be placed in beaker, are subsequently placed in 38 DEG C of waters bath with thermostatic control Heat and stir, then take 3 parts to be slowly added dropwise into gelatin solution the Aprepitant ethanol solution dissolved in S3, add in S4 8% acetic acid solution, regulation pH value is then cold how to room temperature between 4.9, and then solidifies Aprepitant capsule, is received Rice glue capsule, gelatin and Aprepitant ethanol solution mixture in cooling, put mixture with conditions of ice bath, controller temperature For 2 degrees Celsius, and formaldehyde is slowly added dropwise stirs to Aprepitant capsule and be fully cured, Aprepitant capsule after hardening, is used The filter membrane in 200nm apertures carries out filtration sterilization processing;
S6, detection, obtained nanocapsules mixture in S5 is irradiated using e-Pointer, Tyndall scattering inspection is carried out Survey.
Embodiment three
A kind of preparation method of Aprepitant Nano capsule, comprises the following steps:
S1, get the raw materials ready, take gelatin, distilled water, vacuumfilter, powder Aprepitant, acetic acid standby;
S2, gelatin dissolving, take 4 parts of gelatin in S1 to be dissolved in 90 parts of distilled water, in 23 DEG C of stirrings at room temperature to gelatin It is swelled to form colloid, suction filtration then is carried out to colloid using vacuumfilter, the impurity in colloid is removed;
S3, powder Aprepitant dissolving, take 4 parts of powder Aprepitant in S1 to be dissolved in 90 parts of ethanol, at 23 DEG C Stirring is completely dissolved powder Aprepitant at room temperature;
S4, acetic acid solution configuration, glacial acetic acid are dissolved in distilled water, the acetic acid solution of configuration 9%;
S5, raw material mixing, take 12 parts of gelatin in S2 after removal of impurities to be placed in beaker, are subsequently placed in 39 DEG C of waters bath with thermostatic control Heat and stir, then take 4 parts to be slowly added dropwise into gelatin solution the Aprepitant ethanol solution dissolved in S3, add in S4 9% acetic acid solution, regulation pH value is then cold how to room temperature between 5.0, and then solidifies Aprepitant capsule, is received Rice glue capsule, gelatin and Aprepitant ethanol solution mixture in cooling, put mixture with conditions of ice bath, controller temperature For 3 degrees Celsius, and formaldehyde is slowly added dropwise stirs to Aprepitant capsule and be fully cured, Aprepitant capsule after hardening, is used The filter membrane in 200nm apertures carries out filtration sterilization processing;
S6, detection, obtained nanocapsules mixture in S5 is irradiated using e-Pointer, Tyndall scattering inspection is carried out Survey.
Example IV
A kind of preparation method of Aprepitant Nano capsule, comprises the following steps:
S1, get the raw materials ready, take gelatin, distilled water, vacuumfilter, powder Aprepitant, acetic acid standby;
S2, gelatin dissolving, take 5 parts of gelatin in S1 to be dissolved in 100 parts of distilled water, in 24 DEG C of stirrings at room temperature to gelatin It is swelled to form colloid, suction filtration then is carried out to colloid using vacuumfilter, the impurity in colloid is removed;
S3, powder Aprepitant dissolving, take 5 parts of powder Aprepitant in S1 to be dissolved in 100 parts of ethanol, at 24 DEG C Stirring is completely dissolved powder Aprepitant at room temperature;
S4, acetic acid solution configuration, glacial acetic acid are dissolved in distilled water, the acetic acid solution of configuration 10%;
S5, raw material mixing, take 14 parts of gelatin in S2 after removal of impurities to be placed in beaker, are subsequently placed in 40 DEG C of waters bath with thermostatic control Heat and stir, then take 5 parts to be slowly added dropwise into gelatin solution the Aprepitant ethanol solution dissolved in S3, add in S4 10% acetic acid solution, regulation pH value is then cold how to room temperature between 5.1, and then solidifies Aprepitant capsule, is received Rice glue capsule, gelatin and Aprepitant ethanol solution mixture in cooling, put mixture with conditions of ice bath, controller temperature For 4 degrees Celsius, and formaldehyde is slowly added dropwise stirs to Aprepitant capsule and be fully cured, Aprepitant capsule after hardening, is used The filter membrane in 200nm apertures carries out filtration sterilization processing;
S6, detection, obtained nanocapsules mixture in S5 is irradiated using e-Pointer, Tyndall scattering inspection is carried out Survey.
The foregoing is only a preferred embodiment of the present invention, but protection scope of the present invention be not limited thereto, Any one skilled in the art the invention discloses technical scope in, technique according to the invention scheme and its Inventive concept is subject to equivalent substitution or change, should all be included within the scope of the present invention.

Claims (3)

1. a kind of preparation method of Aprepitant Nano capsule, it is characterised in that comprise the following steps:
S1, get the raw materials ready, take gelatin, distilled water, vacuumfilter, powder Aprepitant, acetic acid standby;
S2, gelatin dissolving, take 2-5 parts of gelatin in S1 to be dissolved in 70-100 parts of distilled water, in 20-24 DEG C of stirring at room temperature extremely Gelatin is swelled to form colloid, then carries out suction filtration to colloid using vacuumfilter, removes the impurity in colloid;
S3, powder Aprepitant dissolving, take 2-5 parts of powder Aprepitant in S1 to be dissolved in 70-100 parts of ethanol, in 20-24 DEG C stirring at room temperature be completely dissolved powder Aprepitant;
S4, acetic acid solution configuration, glacial acetic acid are dissolved in distilled water, configure 7-10% acetic acid solution;
S5, raw material mixing, take 8-14 parts of gelatin in S2 after removal of impurities to be placed in beaker, are subsequently placed in 37-40 DEG C of thermostatted water Bath is heated and stirred, and then takes 2-5 parts to be slowly added dropwise into gelatin solution the Aprepitant ethanol solution dissolved in S3, is added 7-10% acetic acid solution in S4, regulation pH value is then cold how to room temperature between 4.8-5.1, and then makes Aprepitant capsule Solidification, obtains Nano capsule;
S6, detection, obtained nanocapsules mixture in S5 is irradiated using e-Pointer, Tyndall scattering detection is carried out.
2. a kind of preparation method of Aprepitant Nano capsule according to claim 1, it is characterised in that the gelatin with Aprepitant ethanol solution mixture puts mixture and under conditions of ice bath, controller temperature is 1-4 degrees Celsius in cooling, And formaldehyde is slowly added dropwise stirs to Aprepitant capsule and be fully cured.
3. the preparation method of a kind of Aprepitant Nano capsule according to claim 1, it is characterised in that described A Rui Smooth capsule after hardening, filtration sterilization processing is carried out using the filter membrane in 200nm apertures.
CN201710429116.0A 2017-06-08 2017-06-08 A kind of preparation method of Aprepitant Nano capsule Pending CN107260705A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710429116.0A CN107260705A (en) 2017-06-08 2017-06-08 A kind of preparation method of Aprepitant Nano capsule

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710429116.0A CN107260705A (en) 2017-06-08 2017-06-08 A kind of preparation method of Aprepitant Nano capsule

Publications (1)

Publication Number Publication Date
CN107260705A true CN107260705A (en) 2017-10-20

Family

ID=60067392

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710429116.0A Pending CN107260705A (en) 2017-06-08 2017-06-08 A kind of preparation method of Aprepitant Nano capsule

Country Status (1)

Country Link
CN (1) CN107260705A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1617712A (en) * 2001-12-10 2005-05-18 麦克公司 Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist
CN101642448A (en) * 2009-06-29 2010-02-10 中南民族大学 Nano-Artesunate capsule and preparation process thereof
US20110009362A1 (en) * 2008-02-27 2011-01-13 Dr. Reddy's Laboratories Ltd. Solubility-enhanced forms of aprepitant and pharmaceutical compositions thereof
CN104586814A (en) * 2015-02-04 2015-05-06 山东新时代药业有限公司 Aprepitant capsules
CN105878250A (en) * 2014-10-29 2016-08-24 北京乐嘉宝医药科技有限责任公司 Aprepitant nano composition

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1617712A (en) * 2001-12-10 2005-05-18 麦克公司 Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist
US20110009362A1 (en) * 2008-02-27 2011-01-13 Dr. Reddy's Laboratories Ltd. Solubility-enhanced forms of aprepitant and pharmaceutical compositions thereof
CN101642448A (en) * 2009-06-29 2010-02-10 中南民族大学 Nano-Artesunate capsule and preparation process thereof
CN105878250A (en) * 2014-10-29 2016-08-24 北京乐嘉宝医药科技有限责任公司 Aprepitant nano composition
CN104586814A (en) * 2015-02-04 2015-05-06 山东新时代药业有限公司 Aprepitant capsules

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
王淑华等: "阿瑞匹坦纳米胶囊的制备", 《药学研究》 *

Similar Documents

Publication Publication Date Title
CN105056243B (en) A kind of pharmaceutical composition of the mesoporous copper sulfide of hyaluronic acid decorated magnetic hollow and preparation method and application
JP2010502594A (en) Method for producing drug-containing polymer microspheres and drug-containing polymer microspheres produced by the method
JP7278413B2 (en) Dispersed Phase Composition for Making Apixaban-Containing Microspheres and Biocompatible Polymer-Based Apixaban-Containing Microspheres Made Therefrom
CN108785275A (en) A kind of preparation method of the targeting being embedded with anticancer drug-optothermal polymerization object particle
CN107260705A (en) A kind of preparation method of Aprepitant Nano capsule
CN105456200B (en) A kind of preparation method and application for the nano mciroball improving insoluble drug oral administration biaavailability
JP5547710B2 (en) Pharmaceutical composition 271
WO2014003677A1 (en) Pharmaceutical compositions comprising solid dispersion particles containing tadalafil
WO2013177927A1 (en) Injection-use esomeprazole sodium lyophilized powder composition and preparation method therefor
CN103211786B (en) Choline fenofibrate film control enteric sustained-release pellet capsule
CN1709236A (en) Fat emulsion containing docetaxel and its preparing method
CN106913519A (en) A kind of preparation method of carbinoxamine maleate slow-release suspension
EP2361623A1 (en) Composition comprising a polyphenol salt and corresponding use
WO2007109929A1 (en) The medicament for treating hyperphospheremia and preparation thereof
CN105434399B (en) A kind of renal cell carcinoma treatment medicine Sutent PLGA/Fe3O4 complex microspheres and preparation method thereof
CN1880301B (en) Tiopronin lysine and its preparing process and use
WO2017000770A1 (en) Pharmaceutical composition and preparation method and use thereof
CN104013582A (en) Aspirin polyethylene glycol-polylactic acid-glycolic acid copolymer (PEG-PLGA) microsphere and preparation method thereof
CN109481419B (en) Rosiglitazone nano preparation and preparation method and application thereof
CN105982877B (en) Puerarin nano crystal capsule and preparation method thereof
CN105924641A (en) Hydroxychloroquine sulfate and polyglutamic acid polymer, as well as preparation method and application thereof
CN106075463A (en) A kind of preparation method of collagen protein medicine magnetic slow-released carrier
CN110974962B (en) Synthesis method of tumor immunity gel preparation
CN1297260C (en) Fatty acyl acetaldehyde powder projection and its preparing method
WO2023274316A1 (en) Application of deuterated plinabulin in preparing drug for treating neutropenia

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20171020

RJ01 Rejection of invention patent application after publication